EdgarLookup

Fulcrum Therapeutics, Inc. — 10-Q Filings

20 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by Fulcrum Therapeutics, Inc. (FULC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Fulcrum Therapeutics, Inc. has filed 20 10-Q documents with the SEC since 2016. To view all SEC filings by Fulcrum Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 4 4/A 424B4 424B5 5 8-A12B 8-K ARS CERT CORRESP D D/A DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP POS AM POS EX POSASR PRE 14A S-1 S-1/A S-3 S-3ASR S-3MEF S-8 SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001193125-25-254633 Oct 29, 2025 Sep 30, 2025
10-Q 10-Q 0000950170-25-099407 Jul 29, 2025 Jun 30, 2025
10-Q 10-Q 0000950170-25-061442 May 1, 2025 Mar 31, 2025
10-Q 10-Q 0000950170-24-125931 Nov 13, 2024 Sep 30, 2024
10-Q 10-Q 0000950170-24-088238 Jul 31, 2024 Jun 30, 2024
10-Q 10-Q 0000950170-24-058193 May 13, 2024 Mar 31, 2024
10-Q 10-Q 0000950170-23-059755 Nov 7, 2023 Sep 30, 2023
10-Q 10-Q 0000950170-23-037579 Aug 3, 2023 Jun 30, 2023
10-Q 10-Q 0000950170-23-021960 May 15, 2023 Mar 31, 2023
10-Q 10-Q 0000950170-22-022913 Nov 8, 2022 Sep 30, 2022
10-Q 10-Q 0000950170-22-016644 Aug 11, 2022 Jun 30, 2022
10-Q 10-Q 0000950170-22-008235 May 9, 2022 Mar 31, 2022
10-Q 10-Q 0001564590-21-054234 Nov 4, 2021 Sep 30, 2021
10-Q 10-Q 0001564590-21-042876 Aug 10, 2021 Jun 30, 2021
10-Q 10-Q 0001564590-21-024505 May 6, 2021 Mar 31, 2021
10-Q 10-Q 0001564590-20-052732 Nov 10, 2020 Sep 30, 2020
10-Q 10-Q 0001564590-20-039121 Aug 11, 2020 Jun 30, 2020
10-Q 10-Q 0001564590-20-024866 May 13, 2020 Mar 31, 2020
10-Q 10-Q 0001564590-19-043378 Nov 14, 2019 Sep 30, 2019
10-Q 10-Q 0001564590-19-032952 Aug 26, 2019 Jun 30, 2019